ALNY vs NCL · P/E 76, rev $1.29B vs rev $5.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Northann Corp. (NCL) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Northann Corp. (NCL) is a furnishings, fixtures & appliances company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported NCL revenue for 2026-03-31 was $5.0M. Net income was -$2.9M. Revenue was up 39.9% from 2025-09-30 to 2026-03-31. NCL currently screens at market cap $9.1M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. NCL currently screens at market cap $9.1M.
Not investment advice. Open the ALNY and NCL stock pages for the full models.
Not investment advice.